about
ATP-binding cassette (ABC) transporters in normal and pathological lungFrom pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatmentLinkage disequilibrium between polymorphisms of ABCB1 and ABCC2 to predict the treatment outcome of Malaysians with complex partial seizures on treatment with carbamazepine mono-therapy at the Kuala Lumpur HospitalA synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function.Association between genetic polymorphisms of MMP8 and the risk of steroid-induced osteonecrosis of the femoral head in the population of northern China.Central neurotoxicity in cancer chemotherapy: pharmacogenetic insights.Pharmacogenetics of antidepressant response.Considerations for extrapolating in vivo bioequivalence data across species and routes.Functional interactions between P-glycoprotein and CYP3A in drug metabolism.Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)Pharmacogenetics in drug regulation: promise, potential and pitfalls.Comparative description of haplotype structure and genetic diversity of MDR1 (ABCB1) in HIV-positive and HIV-negative populations.Effects of rifampin and multidrug resistance gene polymorphism on concentrations of moxifloxacinThe influence of DNA polymorphism of multidrug resistant 1 (MDR1) on the effect of midazolam pretreatment in childrenMechanistic basis of adverse drug reactions: the perils of inappropriate dose schedules.Clinical pharmacogenetics of immunosuppressive drugs in organ transplantation.Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms.Molecular diagnosis of ATP-binding cassette transporter-related diseases.Association of Extrarenal Adverse Effects of Posttransplant Immunosuppression With Sex and ABCB1 Haplotypes.Role of efflux pumps and metabolising enzymes in drug delivery.Pharmacogenomics and lung transplantation: clinical implications.The clinical implications of antiretroviral pharmacogenomics.Active transport across the human placenta: impact on drug efficacy and toxicity.Strategies to assess the drug interaction potential in translational medicine.Membrane transporter proteins: a challenge for CNS drug development.A review on the relation between the brain-serum concentration ratio of drugs and the influence of P-glycoprotein.Pharmacogenetics of Crohn's disease.Pharmacogenetic tests for antipsychotic medications: clinical implications and considerations.Neurological Complications after Renal Transplantation: A Retrospective Clinical Study.A single-nucleotide polymorphism in MMP9 is associated with decreased risk of steroid-induced osteonecrosis of the femoral head.Transporter pharmacogenetics: transporter polymorphisms affect normal physiology, diseases, and pharmacotherapyThe permeability P-glycoprotein: a focus on enantioselectivity and brain distribution.Impact of ATP-binding cassette, subfamily B, member 1 pharmacogenetics on tacrolimus-associated nephrotoxicity and dosage requirements in paediatric patients with liver transplant.Mechanisms of genetic regulation in gene expression: examples from drug metabolizing enzymes and transporters.Pharmacogenetics of drug transporters in the enterohepatic circulation.The pharmacogenomics of sex hormone metabolism: breast cancer risk in menopausal hormone therapy.Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research.Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature.Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications.Steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected Chinese patients.
P2860
Q24811895-177FF493-CD4C-4C57-9972-26B838D4F00FQ27015830-CDB21859-59F2-4807-BFF2-B54720742202Q28533307-7D03F1A9-A5C8-479A-8A0F-8A8ACA166673Q30375556-18FB060F-42E5-4DEB-AE05-D665B1C4A41DQ33595264-40B90054-5877-45DA-828F-05EDE1C6A016Q33857581-4CBEC942-A59B-44AF-8032-889E9A42DA61Q34155796-2E368013-0A9F-4F17-9E6E-4E630083D660Q34194145-56EB3805-4F17-4C68-8ECE-3FBB0DEECC62Q34550483-92FA13DC-A4B8-4D86-A7E1-E98EF36B0FF1Q34994901-53C0254C-689A-4D6A-B674-6C5F088AED91Q35038052-DA1029D5-CE3F-4D10-848E-6F1FF75D119FQ35295887-0E93573A-9849-49B0-AB83-ECD2DA2325E3Q35912661-E076CA21-C670-4377-A525-74A00A5BF816Q35914710-7FF74E79-60C0-406D-A130-8A016A6CFA9CQ36040772-55C3F340-D5B1-4A28-9356-5AD62C2FD380Q36120833-1024E35C-46EC-4B04-8BF4-2774BAAA2099Q36157234-432522B1-73FC-4583-BC8F-5AA125AAD29FQ36252201-A3E1FF58-B057-4CCC-88BC-58B06927FE72Q36256056-1CD216CF-CBE8-4815-AFA9-DCD75401F6F5Q36316872-AA75FCC8-9AE6-4A44-B026-F3B48FAF705CQ36415330-35587345-F302-451E-A218-D07BEE2AFA73Q36497078-9A9E5FF5-0026-4A3B-8B5A-59197AAF9037Q36545029-4C011058-4AEC-4FCF-A491-B100BDB71158Q36609743-0A7AEFEC-0E42-46D1-BA33-8B0A8EECA081Q36659167-D4652CB2-E5F5-4FCD-B7C4-3E91B593DA71Q36914175-811397B5-8F95-4D28-BCCC-CB1FE48CF223Q37205946-F647285C-9FB2-4AA4-B952-C7CAF09BB403Q37344782-9C4C69DF-A6DE-4F3E-8898-E6F31CA4C5D8Q37703907-7A1E3276-D22C-45F9-82FD-8B07B36406E0Q37708812-49541F03-4459-4CD8-8A88-92C975F01CD6Q37735146-75582DCF-BA82-4FB2-814A-81004F3E5C47Q37760941-9AE49A7F-C4F9-4B35-90FB-67EA32B360E2Q37772515-2B7C8F16-E9D2-48EC-B4C2-0A9A9CAFFBBEQ37791990-56BBE43B-FE9E-4A7E-804F-72E013FE2D84Q37880875-A5B516E9-B11D-44AF-B37A-1F2F1D69DE57Q38003702-576C659F-168A-42E5-8FE5-8D622F84CDCCQ38121519-CA7F019A-EB52-4A6C-9E2E-C49FA6D906C7Q38414396-2E359C4F-D9FA-4217-AAAF-CABC9F0AB834Q38484370-3F149EC9-28DF-47D3-91DD-209E73BE48D1Q38798813-58341CC7-C8F7-4C59-BF19-30E7760829B2
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Clinical aspects of the MDR1 (ABCB1) gene polymorphism.
@ast
Clinical aspects of the MDR1 (ABCB1) gene polymorphism.
@en
type
label
Clinical aspects of the MDR1 (ABCB1) gene polymorphism.
@ast
Clinical aspects of the MDR1 (ABCB1) gene polymorphism.
@en
prefLabel
Clinical aspects of the MDR1 (ABCB1) gene polymorphism.
@ast
Clinical aspects of the MDR1 (ABCB1) gene polymorphism.
@en
P2093
P1476
Clinical aspects of the MDR1 (ABCB1) gene polymorphism.
@en
P2093
Martin F Fromm
Matthias Schwab
Michel Eichelbaum
P304
P356
10.1097/00007691-200404000-00017
P577
2004-04-01T00:00:00Z